X0306 4 2019-02-22 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001648920 Rozenman Mary M. AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884 0 1 0 0 See Remarks Common Stock, $0.0001 par value 2019-02-22 4 A 0 7500 0.00 A 14504 D Stock Option (right to buy) 23.72 2019-02-22 4 A 0 45000 0.00 A 2029-02-22 Common Stock 45000 45000 D These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date. Includes 6,875 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date. The shares subject to the option will vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 22, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date. Senior VP, Corporate Development and Strategy /s/ Douglas T. Sheehy, as Attorney in Fact for Mary M. Rozenman 2019-02-26